학술논문

A novel de novo variant in CASKcauses a severe neurodevelopmental disorder that masks the phenotype of a novel de novo variant in EEF2
Document Type
Article
Source
Journal of Human Genetics; August 2023, Vol. 68 Issue: 8 p543-550, 8p
Subject
Language
ISSN
14345161; 1435232X
Abstract
We report a 9-year-old Spanish boy with severe psychomotor developmental delay, short stature, microcephaly and abnormalities of the brain morphology, including cerebellar atrophy. Whole-exome sequencing (WES) uncovered two novel de novo variants, a hemizygous variant in CASK(Calcium/Calmodulin Dependent Serine Protein Kinase) and a heterozygous variant in EEF2(Eukaryotic Translation Elongation Factor 2). CASKgene encodes the peripheral plasma membrane protein CASK that is a scaffold protein located at the synapses in the brain. The c.2506‐6 A > G CASKvariant induced two alternative splicing events that account for the 80% of the total transcripts, which are likely to be degraded by NMD. Pathogenic variants in CASKhave been associated with severe neurological disorders such as mental retardation with or without nystagmus also called FG syndrome 4 (FGS4), and intellectual developmental disorder with microcephaly and pontine and cerebellar hypoplasia (MICPCH). Heterozygous variants in EEF2, which encodes the elongation factor 2 (eEF2), have been associated to Spinocerebellar ataxia 26 (SCA26) and more recently to a childhood-onset neurodevelopmental disorder with benign external hydrocephalus. The yeast model system used to investigate the functional consequences of the c.34 A > G EEF2variant supported its pathogenicity by demonstrating it affects translational fidelity. In conclusion, the phenotype associated with the CASKvariant is more severe and masks the milder phenotype of EEF2variant.